IGC Pharma (IGC) Stock: Buy, Sell, or Hold?
$0.18
-0.01 (-7.24%)
▼
5d:
-2.38%
30d:
-26.76%
90d:
-38.05%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (90%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$0.20 – $0.27
Position: OVERSOLD
Forward P/E & Valuation
-2.1x
Next 12M consensus est.
Wall Street Target
$6.00
+3152.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.18 / $0.21
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When IGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IGC is currently trading at $0.18, which is considered oversold relative to its 30-day fair value range of $0.20 to $0.27.
Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.18, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: IGC scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+3152.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.18, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: IGC scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+3152.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.20 -
$0.27
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$0.20 -
$0.27
Current vs Trading Range
OVERSOLD
Support Level
$0.18
Resistance Level
$0.21
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.2%)
- BULLISH: Trading 3152.0% below Wall St target ($6.00)
- CAUTION: Bottoming setup, but lagging the sector by 17% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$6.00
(+3152.0%)
Revenue Growth (YoY)
-19.2%
Share IGC Analysis
Share this live IGC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IGC)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors on StockTwits are bullish on $IGC following the release of interim Phase II results for IGC-AD1, which demonstrated a larger agitation reduction and stronger effect size than Rexulti.
Key Retail Themes:
Clinical trial results
Competitive advantage
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:25 AM ET
Data refreshes hourly during market hours. Next update: 5:25 AM
Data refreshes hourly during market hours. Next update: 5:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IGC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IGC Research Pages
